Visit other SMART + STRONG sites:
POZREAL HEALTHTU SALUD
Subscribe to:
E-newsletters
POZ magazine
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » Top Stories

Most Popular Stories
Life Expectancy With HIV Increases Dramatically
New Hope for HIV Eradication
New Synthetic Proteins Block HIV
Additional Funding Awarded for Adherence Breathalyzer
A New Avenue Opens for Treating KS, CMV and Other Herpes Diseases
New Life for Treatment Interruptions?
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to editors@aidsmeds.com.

Click here for more news


emailrssprint

December 11, 2008

Blocking CD8 Cell Receptor Prolongs Survival in Monkeys

Blocking a protein called PD1 on immune system cells helped reduced viral loads and increased survival in monkeys infected with a virus similar to HIV, according to the authors of a study published online December 10 in Nature and reported by ScienceDaily.

PD1 receptors are a critical component of the immune system. Their presence on CD8 cells keeps the immune system from over-reacting to infections. Two years ago, researchers reported that there is an overabundance of PD1 proteins on CD8 cells in people with HIV. The scientists proved that the excessive PD1 signaled other immune system cells to stop fighting HIV even though the virus was still present and reproducing. Additional research showed that blocking PD1 in mice improved the ability of CD8 cells to respond to a viral infection. No one knew, however, whether it would be safe to block PD1 in larger animals, such as monkeys and humans.

To explore the safety of blocking PD1, a team of researchers led by Rama Amara, PhD, from the Vaccine Research Center at Emory University in Atlanta, gave PD1-blocking antibodies to nine monkeys infected with SIV (simian immunodeficiency virus). They compared these monkeys, treated four times over a period of 10 days, with five other monkeys who were given a neutral inactive antibody.

All nine of the monkeys who received the anti-PD1 antibodies were still alive seven months after the injections, whereas four of the five monkeys who received the control antibodies died within four months. The immune systems of the monkeys who received the anti-PD1 antibodies also improved significantly, including an increased number of CD8 cells targeting SIV and production of SIV-fighting antibodies.

“It…is important to note that this therapy was effective without antiretroviral drugs and in monkeys with severe AIDS,” Amara said. The researchers plan to continue developing and refining the process for blocking PD1. They also plan to try it against other chronic diseases, such as hepatitis C virus (HCV) infection.

Search: PD1, CD8, Rama Amara, Emory University


Scroll down to comment on this story.

emailrssprint

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

       


[Go to top]

Quick Links
AIDSmeds en Español
About HIV and AIDS
Lab Tests
My Cool Tools
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine
Conference Coverage

CROI 2009
Montréal, Canada
February 8-11, 2009


48th Annual ICAAC/IDSA 46th Annual Meeting
Washington, DC
October 25-28, 2008


XVII International AIDS Conference
Mexico City, Mexico
August 3-8, 2008


more conference coverage


[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2009 Smart + Strong. All Rights Reserved. Terms of use and Your privacy